- Citations, last 5 years
- 57
- Works, last 5 years
- 7
- h-index
- 18
- Scientists listed
- 1
- Grants since 2016
- 9
Grants received
2022–2023 · research · R43
Identification of mechanism-based therapies to treat arrhythmogenic cardiomyopathy by resolving perturbations in regulatory lipid signaling
Irene Cortes-Puch · Eicosis (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Inhibiting soluble epoxide hydrolase as a treatment for chemotherapy inducedperipheral neuropathic pain
Alan R Buckpitt · Eicosis (United States) · funded by National Institutes of Health
2019–2026 · cooperative agreement · UH3
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
Irene Cortes-Puch · Eicosis (United States) · funded by National Institutes of Health
2019–2021 · cooperative agreement · UG3
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
Alan R Buckpitt · Eicosis (United States) · funded by National Institutes of Health
2019–2022 · cooperative agreement · UG3
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
Alan R Buckpitt · Eicosis (United States) · funded by National Institutes of Health
2019–2026 · cooperative agreement · UH3
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics
Irene Cortes-Puch · Eicosis (United States) · funded by National Institutes of Health
2016–2017 · cooperative agreement · UH2
Development of an Oral Analgesic for Neuropathic Pain
Alan R Buckpitt · Eicosis (United States) · funded by National Institutes of Health
2016–2019 · cooperative agreement · UH3
Development of an Oral Analgesic for Neuropathic Pain
Alan R Buckpitt · Eicosis (United States) · funded by National Institutes of Health
2016–2017 · cooperative agreement · UH2
Development of an Oral Analgesic for Neuropathic Pain
Alan R Buckpitt · Eicosis (United States) · funded by National Institutes of Health
